The company’s vast library of samples offers researchers at the Michael J. Fox Foundation the unique opportunity to analyze plasma samples that go back up to 10 years.

Michael J. Fox made an emotional and rare comment about his Parkinson’s disease on Tuesday. The 62-year-old “Back to the Future” star spoke on a panel about his foundation for Parkinson’s ...

Find the latest michael j. fox foundation news from Fast company. See related business and technology articles, photos, slideshows and videos.

In 2000, Michael J. Fox retired from full-time acting to concentrate on advocacy work, where he established the Michael J. Fox Foundation for Parkinson’s Research, which has since become the ...

The Michael J. Fox Foundation had its annual A Funny Thing Happened On The Way To Cure Parkinson's gala on Saturday night, and Fox's "Back to the Future" co-star Christopher Lloyd made an appearance.

Michael J. Fox is an award-winning actor, bestselling author and founder of The Michael J. Fox Foundation for Parkinson’s Research. He was diagnosed with Parkinson’s disease at age 29.

The Michael J. Fox Foundation Chicago Run/Walk to raise funds and awareness for Parkinson’s disease is a symbol of hope and resilience The Brice Family shares their story.

At the Michael J. Fox Foundation's annual A Funny Thing Happened on the Way to Cure Parkinson’s gala on Saturday, Nov. 16, the Back to the Future actor, 63, chatted with PEOPLE about his dark ...

Michael J. Fox, who was diagnosed with Parkinson’s in the early 1990s, doesn’t fear dying, only what happens to his family.

Martin Scorsese praised Michael J. Fox for his Parkinson’s foundation, which he said is “leading the charge toward a world without Parkinson’s disease.” Since its conception, the Michael J ...

Michael J. Fox is an award-winning actor, best-selling author, and founder of The Michael J. Fox Foundation for Parkinson’s Research. He was diagnosed with Parkinson’s disease in 1991.

And the Michael J. Fox Foundation, now in its 25th year, is a leader in Parkinson’s research, funding over $2 billion in studies and accelerating 19 new treatments to market.